Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Competitive Landscape Professional Research Report 2024

Research Summary

PARP (Poly ADP-Ribose Polymerase) inhibitors are a class of pharmaceutical drugs that are primarily used in cancer treatment, particularly for certain types of breast, ovarian, and prostate cancers. PARP is an enzyme involved in DNA repair within cells. PARP inhibitors work by blocking this enzyme, preventing cancer cells from effectively repairing DNA damage, and leading to their death. These drugs are especially effective in cancer cells with specific genetic mutations, such as BRCA mutations, which impair their ability to repair DNA damage. By exploiting this vulnerability, PARP inhibitors can selectively target and kill cancer cells while sparing normal, healthy cells. They represent a significant advancement in targeted cancer therapy and have shown promising results in clinical trials for various cancer types.

According to DIResearch's in-depth investigation and research, the global PARP (Poly ADP-Ribose Polymerase) Inhibitor market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of PARP (Poly ADP-Ribose Polymerase) Inhibitor include AstraZeneca, Tesaro, Merck, Clovis Oncology, Pfizer, GSK, Zai Lab etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of PARP (Poly ADP-Ribose Polymerase) Inhibitor. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global PARP (Poly ADP-Ribose Polymerase) Inhibitor market. The report data covers historical data from 2018 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the PARP (Poly ADP-Ribose Polymerase) Inhibitor market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of PARP (Poly ADP-Ribose Polymerase) Inhibitor industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of PARP (Poly ADP-Ribose Polymerase) Inhibitor Include:

AstraZeneca

Tesaro

Merck

Clovis Oncology

Pfizer

GSK

Zai Lab

PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Segment Include:

Sinemet-CR

Trastal

Madopar

COMT Inhibitor

Others

PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Application Include:

Under 40 Years Old

40-65 Years Old

Above 65 Years Old

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Capacity and Production Analysis

Chapter 3: Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Industry PESTEL Analysis

Chapter 4: Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Industry Porter's Five Forces Analysis

Chapter 5: Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 6: Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Forecast by Type and Application Analysis

Chapter 7: North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: China PARP (Poly ADP-Ribose Polymerase) Inhibitor Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: APAC (Excl. China) PARP (Poly ADP-Ribose Polymerase) Inhibitor Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Latin America PARP (Poly ADP-Ribose Polymerase) Inhibitor Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Middle East and Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 13: Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 14: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 15: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 16: Research Findings and Conclusion

Chapter 17: Methodology and Data Sources

Table of Contents

1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Overview

1.1 Product Definition and Statistical Scope

1.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Product by Type

1.2.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Sinemet-CR

1.2.3 Trastal

1.2.4 Madopar

1.2.5 COMT Inhibitor

1.2.6 Others

1.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Product by Application

1.3.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Under 40 Years Old

1.3.3 40-65 Years Old

1.3.4 Above 65 Years Old

1.4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Revenue and Sales Analysis

1.4.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Analysis (2019-2030)

1.4.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Sales Analysis (2019-2030)

1.4.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Sales Price Trend Analysis (2019-2030)

1.5 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Development Status and Trends

1.5.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Industry Development Status Analysis

1.5.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Industry Development Trends Analysis

2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Capacity and Production Analysis

2.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Capacity (2019-2030)

2.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production by Region: 2023 VS 2024 VS 2030

2.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production by Region

2.3.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Historic Production by Region (2019-2024)

2.3.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Forecasted Production by Region (2025-2030)

2.3.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Production Market Share by Region (2019-2030)

3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market PESTEL Analysis

3.1 Political Factors Analysis

3.2 Economic Factors Analysis

3.3 Social Factors Analysis

3.4 Technological Factors Analysis

3.5 Environmental Factors Analysis

3.6 Legal Factors Analysis

4 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Porter's Five Forces Analysis

4.1 Competitive Rivalry

4.2 Threat of New Entrants

4.3 Bargaining Power of Suppliers

4.4 Bargaining Power of Buyers

4.5 Threat of Substitutes

5 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Analysis by Regions

5.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Overall Market: 2023 VS 2024 VS 2030

5.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Forecast Analysis (2019-2030)

5.2.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Market Share by Region (2019-2024)

5.2.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Forecast by Region (2025-2030)

5.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales and Forecast Analysis (2019-2030)

5.3.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales and Market Share by Region (2019-2024)

5.3.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Forecast by Region (2025-2030)

5.4 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Price Trend Analysis (2019-2030)

6 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type and Application

6.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type

6.1.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Forecast Analysis by Type (2019-2030)

6.1.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales and Forecast Analysis by Type (2019-2030)

6.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application

6.2.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue and Forecast Analysis by Application (2019-2030)

6.2.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales and Forecast Analysis by Application (2019-2030)

7 North America

7.1 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate Analysis (2019-2030)

7.2 North America Key Manufacturers Analysis

7.3 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type

7.3.1 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales by Type (2019-2030)

7.3.2 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Type (2019-2030)

7.4 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application

7.4.1 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales by Application (2019-2030)

7.4.2 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Application (2019-2030)

7.5 North America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Country

7.5.1 US

7.5.2 Canada

8 Europe

8.1 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate Analysis (2019-2030)

8.2 Europe Key Manufacturers Analysis

8.3 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type

8.3.1 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales by Type (2019-2030)

8.3.2 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Type (2019-2030)

8.4 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application

8.4.1 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales by Application (2019-2030)

8.4.2 ? Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Application (2019-2030)

8.5 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Country

8.5.1 Germany

8.5.2 France

8.5.3 United Kingdom

8.5.4 Italy

8.5.5 Spain

8.5.6 Benelux

9 China

9.1 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate Analysis (2019-2030)

9.2 China Key Manufacturers Analysis

9.3 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type

9.3.1 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales by Type (2019-2030)

9.3.2 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Type (2019-2030)

9.4 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application

9.4.1 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales by Application (2019-2030)

9.4.2 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Application (2019-2030)

10 APAC (excl. China)

10.1 APAC (excl. China) PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate Analysis (2019-2030)

10.2 APAC (excl. China) Key Manufacturers Analysis

10.3 APAC (excl. China) PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type

10.3.1 APAC (excl. China) PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales by Type (2019-2030)

10.3.2 APAC (excl. China) PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Type (2019-2030)

10.4 APAC (excl. China) PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application

10.4.1 APAC (excl. China) PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales by Application (2019-2030)

10.4.2 APAC (excl. China) PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Application (2019-2030)

10.5 APAC (excl. China) PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Country

10.5.1 Japan

10.5.2 South Korea

10.5.3 India

10.5.4 Australia

10.5.5 Indonesia

10.5.6 Vietnam

10.5.7 Malaysia

10.5.8 Thailand

11 Latin America

11.1 Latin America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate Analysis (2019-2030)

11.2 Latin America Key Manufacturers Analysis

11.3 Latin America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type

11.3.1 Latin America PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales by Type (2019-2030)

11.3.2 Latin America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Type (2019-2030)

11.4 Latin America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application

11.4.1 Latin America PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales by Application (2019-2030)

11.4.2 Latin America PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Application (2019-2030)

11.5 Latin America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Country

11.5.1 Mexico

11.5.2 Brazil

12 Middle East & Africa

12.1 Middle East & Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate Analysis (2019-2030)

12.2 Middle East & Africa Key Manufacturers Analysis

12.3 Middle East & Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type

12.3.1 Middle East & Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales by Type (2019-2030)

12.3.2 Middle East & Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Type (2019-2030)

12.4 Middle East & Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application

12.4.1 Middle East & Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales by Application (2019-2030)

12.4.2 Middle East & Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Application (2019-2030)

12.5 Middle East & Africa PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Country

12.5.1 Saudi Arabia

12.5.2 South Africa

13 Competition by Manufacturers

13.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

13.1.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Sales by Key Manufacturers (2020-2024)

13.1.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Revenue by Key Manufacturers (2020-2024)

13.1.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Average Sales Price by Manufacturers (2020-2024)

13.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Competitive Landscape Analysis and Market Dynamic

13.2.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Competitive Landscape Analysis

13.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

13.2.3 Market Dynamic

14 Key Companies Analysis

14.1 AstraZeneca

14.1.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

14.1.2 AstraZeneca PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Portfolio

14.1.3 AstraZeneca PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14.2 Tesaro

14.2.1 Tesaro Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

14.2.2 Tesaro PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Portfolio

14.2.3 Tesaro PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14.3 Merck

14.3.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

14.3.2 Merck PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Portfolio

14.3.3 Merck PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14.4 Clovis Oncology

14.4.1 Clovis Oncology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

14.4.2 Clovis Oncology PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Portfolio

14.4.3 Clovis Oncology PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14.5 Pfizer

14.5.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

14.5.2 Pfizer PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Portfolio

14.5.3 Pfizer PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14.6 GSK

14.6.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

14.6.2 GSK PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Portfolio

14.6.3 GSK PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14.7 Zai Lab

14.7.1 Zai Lab Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

14.7.2 Zai Lab PARP (Poly ADP-Ribose Polymerase) Inhibitor Product Portfolio

14.7.3 Zai Lab PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

15 Industry Chain Analysis

15.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Industry Chain Analysis

15.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Industry Upstream Supply Analysis

15.2.1 Upstream Key Raw Material Supply Analysis

15.2.2 Raw Material Suppliers and Contact Information

15.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Typical Downstream Customers

15.4 PARP (Poly ADP-Ribose Polymerase) Inhibitor Sales Channel Analysis

16 Research Findings and Conclusion

17 Methodology and Data Source

17.1 Methodology/Research Approach

17.2 Research Scope

17.3 Benchmarks and Assumptions

17.4 Date Source

17.4.1 Primary Sources

17.4.2 Secondary Sources

17.5 Data Cross Validation

17.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Polystyrene-Plastic Material And Resins Market (2024 Edition): Analysis By End-User Industry (Packaging Industry, Construction, Consumer, Electronics, and Other End-User Industries), By Product Type, By Application, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Ultra High Molecular Weight Polyethylene (UHMWPE) Fiber Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Form (Tapes, Sheets and Films, Fibers, Rods & Tubes and Other Forms), Processing Method, Grade, Region, By Country: 2020-2030

Global Food & Beverage Non-woven Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Material (Polypropylene (PP), Polyethylene Terephthalate (PET), Polyethylene, Rayon and Other Materials), Product Type, End-Use, Region, By Country: 2020-2030

Global Transportation Protective Films Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Material Type (PP Films, PE Films, PVC Films, PET Films and Other Material Types), End-Use Industry, Class Type, Region, By Country: 2020-2030

Global Short Fiber Thermoplastic Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Resin Type (Polypropylene, Polyamide, PEEK, PBT and Other Resin Types), Application, Reinforcement Type, Region, By Country: 2020-2030

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support